SII and Symbiosis International University sign MoU to set up research centre for vaccine and biologicals Read more
Myovant Sciences and Accord Healthcare enter into exclusive licence agreement to commercialise Orgovyx for prostate cancer in Europe Read more
US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with COVID-19 Read more